|
PBYI | Puma Biotechnology, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.48 |
| Leverage | 43.18% |
| Market Cap | $ 238.6m |
| PE | 6.47 |
| Dividend Yield | 0.00% |
| Profit | $ 36.9m |
| Margin | 17.34% |
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States and internationally. The company is headquartered in Los Angeles, California.